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Abstract
Background: Telemedicine has emerged as an innovative platform to diagnose and treat psychiatric disorders in a cost-effective
fashion. Previous studies have laid the functional framework for monitoring and treating child psychiatric disorders electronically
using videoconferencing, mobile phones (smartphones), and Web-based apps. However, phone call and text message (short
message service, SMS) interventions in adolescent psychiatry are less studied than other electronic platforms. Further investigations
on the development of these interventions are needed.
Objective: The aim of this paper was to explore the utility of text message interventions in adolescent psychiatry and describe
a user feedback-driven iterative design process for text message systems.
Methods: We developed automated text message interventions using a platform for both depression (EpxDepression) and autism
spectrum disorder (ASD; EpxAutism) and conducted 2 pilot studies for each intervention (N=3 and N=6, respectively). The
interventions were prescribed by and accessible to the patients’ healthcare providers. EpxDepression and EpxAutism utilized an
automated system to triage patients into 1 of 3 risk categories based on their text responses and alerted providers directly via
phone and an online interface when patients met provider-specified risk criteria. Rapid text-based feedback from participants and
interviews with providers allowed for quick iterative cycles to improve interventions.
Results: Patients using EpxDepression had high weekly response rates (100% over 2 to 4 months), but exhibited message fatigue
with daily prompts with mean (SD) overall response rates of 66.3% (21.6%) and 64.7% (8.2%) for mood and sleep questionnaires,
respectively. In contrast, parents using EpxAutism displayed both high weekly and overall response rates (100% and 85%,
respectively, over 1 to 4 months) that did not decay significantly with time. Monthly participant feedback surveys for EpxDepression
(7 surveys) and EpxAutism (18 surveys) preliminarily indicated that for both interventions, daily messages constituted the “perfect
amount” of contact and that EpxAutism, but not EpxDepression, improved patient communication with providers. Notably,
EpxDepression detected thoughts of self-harm in patients before their case managers or caregivers were aware of such ideation.
Conclusions: Text-message interventions in adolescent psychiatry can provide a cost-effective and engaging method to track
symptoms, behavior, and ideation over time. Following the collection of pilot data and feedback from providers and patients,
larger studies are already underway to validate the clinical utility of EpxDepression and EpxAutism.
Trial Registration: Clinicaltrials.gov NCT03002311; https://clinicaltrials.gov/ct2/show/NCT03002311 (Archived by WebCite
at http://www.webcitation.org/6qQtlCIS0)
JMIR Res Protoc 2017 | vol. 6 | iss. 6 | e114 | p.1http://www.researchprotocols.org/2017/6/e114/
(page number not for citation purposes)
Chen et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
(JMIR Res Protoc 2017;6(6):e114)   doi:10.2196/resprot.7245
KEYWORDS
telemedicine; depression; autistic disorder; mobile applications; text messaging; child; mental health
Introduction
Psychiatric disorders in adolescent populations are extremely
common, with a lifetime prevalence estimated up to 46.3%
among individuals 13 to 18 years old [1]. As such, mental health
disorders among US children have an estimated total annual
cost of US $247 billion, with adolescents comprising the
majority of these costs [2]. With the advent of mobile technology
over the past two decades, there is an increasing need for
innovative solutions to deliver inexpensive mental healthcare
to our adolescent populations [3,4]. Telepsychiatry is a rapidly
evolving field that promises to bridge evidence-based medicine
with populations traditionally unable to connect with standard
of care [5,6]. While videoconferencing remains the predominant
evidence-based platform in telemedicine, phone-based
interventions are another accessible and cost-effective method
to target a variety of mental health conditions [7]. Here, we
discussed the development of provider-prescribed automated
text message (short message service, SMS) and phone call
interventions for adolescent psychiatric disorders and their
potential for improving patient outcomes.
Adolescent Depression
Unipolar major depression (major depressive disorder, MDD)
is a psychiatric disorder in which patients suffer at least one
major depressive episode that causes significant distress or
impairment in daily function, not attributable to mania or other
causes [8]. In children between the ages of 10 and 19 years, the
12-month prevalence of major depression is estimated to be
7.5%, increasing significantly through adolescence and rising
more quickly than in adults [2,9]. While the prevalence of
depressive disorders increases with age for both sexes,
adolescent females report a higher average percentage (25%)
of depressive symptoms than their male (10%) counterparts
[9-12]. Adolescents with depression exhibit decreased
productivity in school leading to higher dropout rates, increased
anxiety and anger, increased risk of developing other psychiatric
and medical illnesses such as substance use disorder, and
dramatically increased rates of suicide [13-19]. Currently, the
main treatment options for adolescent depression are
pharmacotherapy, psychotherapy, or a combination of both [20].
However, due to a high rate of non-compliance and
non-responders, continual monitoring is critical to ensure
optimal medication titration, decreased suicide rates, remission,
and complete functional recovery [21-23]. Because
underdiagnosis and undertreatment are common problems in
adolescent depression, an annual depression screen using the
9-question Patient Health Questionnaire-9 (PHQ-9) or 2-question
PHQ-2 is recommended for all adolescents beginning at the age
of 12 until they are 21 [24-26].
Digital platforms are being explored both for screening
adolescents at risk for major depression as well as for treatment
of major depression in order to minimize costs, improve
treatment adherence, optimize pharmacological titration, better
track and manage symptoms, side effects, suicidality, and reduce
behaviors that increase the risk of relapse. For example, a
number of promising computerized cognitive behavioral therapy
(cCBT) programs have been implemented in school settings
with consistent success [23,24,27-30]. Another
example—at-home depression questionnaires administered over
mobile devices—have been used to remotely monitor clinically
relevant metrics such as the PHQ-9 with remarkable sensitivity
and specificity and little variability across race, gender, and age
[31,32].
Intriguingly, telemedicine may be uniquely positioned to help
depressive adolescents who have consistently responded
positively to telemedicine interventions [33-35]. Because
depressive adolescents are often reluctant to seek help from
social networks, text-based interventions and crisis hotlines
have emerged as highly utilized platforms for patients [36].
Adolescents often prefer the convenience, discreteness, increased
communication effectiveness, and reduced anxiety associated
with texting or talking on the phone compared with in-person
evaluations with a physician [37]. Lublin and colleagues at
DoSomething, an organization which uses texting to recruit
volunteers for social advocacy programs, founded Crisis Text
Line in 2013 after seeing an increasing number of teens using
the text messaging system to report emotional crises and seek
support [38]. Crisis Text Line is now one of the nation’s largest
crisis text-based hotlines and has processed over 28 million
texts to date [39]. As such, text message interventions present
a unique intersection between adoptability and utility for
detecting depression and even suicidality among adolescents.
Adolescent Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental
disorder characterized by deficits in social communication and
social interaction and the presence of restricted and repetitive
patterns of behavior, interests, and activities [8]. Diagnosis,
behavioral treatment, and monitoring children with ASD are
still in its infancy. Managing ASD is time-intensive and costly
and primarily consists of cognitive behavior therapy (CBT)
interventions that target development and learning, social skills,
and reducing maladaptive behaviors [40]. Although medications
are commonly prescribed, they mainly target comorbid
conditions and control symptoms, but do not provide treatment
for underlying deficits [41]. Importantly, treatment for ASD is
most effective when initiated early on and requires frequent
follow-up adjustment cycles to be effective. This creates major
barriers to care including time, cost, delayed diagnosis, access
to specialists, and treatment adherence [42,43]. Aside from
questionnaires taken during appointments (which are subject to
recall bias), there are limited ways to monitor patient behaviors
longitudinally between physician visits [44,45]. As such, there
is a critical need to develop inexpensive methods to identify
and monitor adolescents with ASD.
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Digital platforms have emerged as new ways to improve access
to care and better monitor adolescents with ASD. Most
interventions have focused predominantly on mobile apps and
videoconference services. Services that have been provided
remotely through videoconference platforms include: primary
evaluations for patients with ASD [46,47], cognitive behavioral
interventions [48], and training healthcare professionals in rural
areas to provide interventions to children with ASD [49].
Telemedicine systems that provide patients who live in rural
areas with access to diagnostics and cCBT are capable of
delivering medical care at dramatically reduced costs, without
sacrificing diagnostic accuracy, quality, or patient satisfaction
[50,51]. Mobile apps are another method for delivering services
to children with ASD and their families remotely and
electronically [52]. Because mobile apps are point-of-care,
physicians can track patients’ symptoms with astounding
temporal resolution. While these apps have developed more
recently than video-based telehealth interventions, apps for
surveying high-functioning ASD patients in real-time [53],
teaching parents about ASD and treatment options [42], and
social skills-building programs [54] already exist.
The benefits of electronic apps are wide-ranging. Enabled by
portable computers and mobile devices, sampling methods such
as ecological momentary assessment—the process of repeatedly
sampling behaviors or experiences in situ in real-time—have
been shown to reduce episodic memory decay and recall biases
as compared to retrospective questionnaires in patients with
high-functioning autism [53]. Moreover, responses on mobile
apps reliably matched standard-of-care questionnaires used in
clinical practice, making mobile symptom and side-effect
tracking a promising option for ASD patients [53]. Though
real-time data-driven apps that are used by patients (as opposed
to their parents) have the limitation of being applicable primarily
to those with high-functioning ASD, the emergence of mobile
technologies that cater to patients with ASD that have lower
cognitive function continue to prove promising [55].
Phone call and text interventions in adolescent mental health,
and especially in adolescent depression and ASD, offer
promising ways to improve care, with unique advantages over
other digital interventions such as teleconferencing or mobile
apps. First, while access to videoconferencing and mobile
devices may be limited, phone access is ubiquitous, with more
than 90% of the population having access to a mobile phone
[56]. Therefore, phone calls and text messaging offer
inexpensive alternatives to apps requiring mobile phones with
app capabilities (smartphone) or standalone devices. Second,
automated texting and calling platforms allow proactive
prompting, which improves engagement over mobile apps and
allows highly resolved treatment, symptom, and side effect
tracking. Third, texting is the primary mode of communication
for adolescents, making text-delivered interventions a natural
extension of communication with patients’ healthcare providers.
As such, we set out to build text message interventions for
adolescent depression and autism using a patient-centric design
process that addressed some of the major pain points in the field.
Methods
Epharmix is an automated texting and calling platform that
sends standardized, condition-specific texts or calls to patients
or their designated caregivers to track symptoms longitudinally
in real-time, provide educational content to patients, and trigger
smart alerts to providers when patients report concerning
symptoms or behaviors. Two specific interventions for
depression and ASD, called EpxDepression and EpxAutism,
respectively, have been developed. EpxDepression and
EpxAutism were developed using a human-centric design
methodology that involved identifying and interviewing
seasoned clinicians, research scientists, and biostatisticians in
adolescent psychiatry, conducting an extensive literature review,
developing optimal questions, alert thresholds, and a clinical
decision tree (together known as the “algorithm”), running a
small-scale pilot study in a clinically relevant adolescent
population as a method for validating algorithm parameters,
analyzing data and iterate on the algorithm, using both user
feedback and continued research, and interfacing with seasoned
clinicians. The unique iteration and development cycle allows
rapid, data-driven improvements of the Epharmix systems.
Currently, we have run a small pilot for both EpxDepression
and EpxAutism and are updating each algorithm based on our
results, as well as feedback from providers and patients. These
implementations were submitted to the institutional review
board (IRB) for review and advised to be pursued as quality
improvement (QI) projects. Consent for these studies was
received from patients via the Washington University in St
Louis “Authorization to utilize unencrypted email/ text messages
to communicate protected health information” form as well as
verbal consent from patients in accordance with their provider.
EpxDepression
EpxDepression prompts the patient or caregiver for subjective
mood and sleep ratings on a 10-point rating scale every day,
and sends a text-based modified PHQ-9 every 2 weeks or month,
depending on the provider’s assessment of the patient (Figure
1). While the modified PHQ-9 is administered through a text
message platform as opposed to in-person, its scoring function
was adapted to give an equivalent score to the original PHQ-9.
Depending on the patient’s mood, PHQ-9 score, and self-harm
ideation (a positive response on the last question of the PHQ-9),
the patient is triaged into a red-yellow-green hierarchy. Patients
who are scored as high-risk (red) are automatically reported to
the care team. Importantly, patients who report self-harm
behavior are automatically directed to a suicide help-line, crisis
manager, or entrusted caregiver (Figure 1).
In our initial pilot study with EpxDepression, our primary aim
was to assess patient engagement with an automated texting
platform. We enrolled 3 adolescent patients with MDD in
EpxDepression and assessed their weekly response rates to the
mood, sleep, and PHQ-9 prompts. A weekly response is defined
as having answered at least 1 question during the week for the
associated prompt. The frequency of the PHQ-9 questionnaire
was determined by the specific program the patient was placed
in (once every 2 weeks or once a month), while the mood and
sleep questions were asked daily. The duration of enrollment
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varied on a case-by-case basis, spanning anywhere from 2 to 4
months.
EpxAutism
In our initial pilot with EpxAutism, 6 adolescent patients with
ASD and their parents were enrolled in the study. The duration
of enrollment varied on a case-by-case basis, spanning anywhere
from 18 to 110 days. EpxAutism prompted each patient’s
caregiver daily for the patient’s quality of life, the number of
meltdowns the patient has had in the last 24 hours, and the
duration of the longest meltdown (Figure 2). The system
synthesized data received through text responses for each
individual and triaged patients into 1 of 3 risk categories
including red (high risk), yellow (moderate risk), and green
(low risk) based on a change in meltdown frequency and
duration as set by their provider and sent alerts to providers
upon recognizing significant upward deviations in recorded
meltdowns.
The aim of EpxAutism was to improve a provider’s ability to
monitor patient behavior and symptoms between visits, foster
communication between the patient and provider, and improve
survey compliance and health outcomes for the patient. Our
primary outcome was weekly response rates, but we were also
interested in overall response rates, behavioral metrics reported
by the caregivers, and feedback from parents using the system.
Similar to our pilot study with EpxDepression, weekly response
was defined as having answered at least 1 question during the
week for the associated prompt, and overall response rate was
defined as the number of prompts answered divided by the
number of prompts sent to the parent.
Figure 1. EpxDepression automated text message algorithm.
Figure 2. EpxAutism automated text message algorithm.
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Textbox 1. Survey prompts.
Prompt
• Communication: On a scale of 1 to 9, do you think this service improved communication with your doctor? (1 = significantly worsened, 5 = no
change, 9 = significantly improved).
• Frequency: On a scale of 1 to 9, how do you feel about the number of messages you received through our service? (1 = too few, 5 = perfect
amount, 9 = too many).
• Improvement: How could we make this service better? Feel free to write as much as you would like.
• Positive Comment: What did you like about this service? Feel free to write as much as you would like.
User Feedback
Users were sent monthly surveys through text messages which
asked for subjective feedback on the EpxDepression or
EpxAutism systems. Deidentified survey data was used
frequently to iterate on specific questions, timing of messages,




We found that with the mood, sleep, and PHQ-9 questionnaires,
patients maintained a 100% weekly response rate during their
enrollment in the study, indicating that no patients were lost to
follow-up. However, overall response rates for mood and sleep,
defined as the percentage of questionnaires completed for mood,
sleep, or PHQ-9 whenever prompted, was markedly lower
(Figure 3). The mean (SD) daily response rate for mood was
66.3% (21.6%) and sleep was 64.7% (8.2%). The response rates
decreased over time, with the sleep prompt having lower
response rates and greater decay than the mood prompt from
the outset (Figure 3). Our preliminary data suggested that
adolescents with MDD engaged with prompts on a weekly basis
in a robust fashion, but underwent message fatigue with daily
prompts. A larger study will be necessary to confirm our
findings.
While our primary outcome was weekly response rates over
time, we wanted to determine whether self-reported mood or
sleep ratings could predict a patient’s PHQ-9 score as suggested
in other studies [34]. We averaged each patient’s mood or sleep
ratings leading up to a PHQ-9 prompt, and regressed these
averages against the patient’s PHQ-9 score for that time point.
Based on our data, mood (R2=.20, P=.12) and sleep (R2=.14,
P=.26) were not significantly correlated to the PHQ-9 score,
although both trended toward a negative correlation as might
be expected (Figure 4). Self-reported mood ratings were
positively correlated with sleep ratings (R2=.61, P=.005) and
consistent with the literature (Figure 4). Due to the small sample
size, these results are suggestive; future studies with a larger
sample size will be needed to determine whether self-reported
mood and sleep ratings can predict self-reported PHQ-9 scores
collected through automated text-messaging.
Despite the small sample size, the EpxDepression module has
already made a tangible impact in the lives of our patients.
EpxDepression is programmed to automatically alert the
patient’s care provider if the patient reports a positive response
to the suicidal ideation question (question 9) on the PHQ-9
survey. In the 2 patients who scored positively on this question,
EpxDepression detected and alerted the patients’ care providers
of the patients’ self-harm ideations, even before the case
manager was aware that the patient was having these thoughts.
The case manager was able to follow-up with each patient and
confirm that the patient was having suicidal ideation, and care
was modified appropriately. These instances demonstrated that
patients with MDD in our study were willing to disclose suicidal
ideation through text-messaging before telling their case
manager or families in person.
From adolescent patients enrolled in EpxDepression, 7 feedback
surveys were completed where users answered a valid response
for at least 1 of the prompts. From the small sample size, users
indicated that the number of messages received was the “perfect
amount” (median=5) where 1 was too few, 5 was the perfect
amount, and 10 was too many. There was no improvement in
communication between patient and provider attributed to the
intervention, as observed by a mean value of 5, where 1
indicated significantly worsened, 5 indicated no change, and 9
indicated significantly improved. Positive feedback commonly
included improved feeling of support and contact between
patient and provider:
“Knowing my Dr [sic] is in contact and aware of my
answers.”
“I like the daily contact.”
“Service gave me feeling of daily contact with my Dr
[sic].”
Despite indicating that there may not have been any
improvement in communication with providers, no patient
provided any negative feedback based on survey results. Most
feedback included confirmation of “service works fine” or
“service is great” when queried for areas of improvement.
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Figure 3. EpxDepression patient overall response rates.
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Figure 4. EpxDepression correlations between outcomes.
EpxAutism
The weekly response rate for parents using EpxAutism was
100%, indicating a robust and prolonged enrollment in the
system that did not decay with time. Remarkably, the mean
(SD) overall response rate even with daily questions was 85%
(29.1%) (Figure 5). Unlike with mood and sleep prompts in
EpxDepression, there was no significant difference between
overall response rates between individual prompts in EpxAutism.
High engagement rates were maintained throughout the duration
of the pilot. Our data suggested that EpxAutism is an engaging
system for caregivers with children with ASD and may be used
to better track concerning symptoms and behaviors on a daily
basis.
Participants enrolled in EpxAutism completed 18 surveys in
which a valid response for at least 1 of the prompts was
submitted. When queried about communication between patient
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and providers, users responded to “On a scale of 1 to 9, do you
think this service improved communication with your doctor?”
On this scale, 1 indicated significantly worsened, 5 indicated
no change, and 9 indicated significantly improved. The
determined median score of 7 indicated an improvement in
communication from use of EpxAutism.
In terms of frequency of text messages, parents received 3
prompts daily about their child’s behavior. When surveyed,
parents responded to “On a scale of 1 to 9, how do you feel
about the number of messages you received through our service?
On this scale, 1 indicated too few, 5 indicated the perfect
amount, and 9 indicated too many. Patients reported a median
response value of 5.
Positive comments often reflected the importance of daily
communication and feeling connected with their provider:
“Daily contact and reporting is what we need to help
identify issues and help our son.”
“More communication is better and daily tracking is
needed. Thanks.”
“The service is great. I appreciate all that [provider]
has done to teach [my son] to better control himself
and he has helped me with ways to help my son as
well. I liked having a record of [my son’s]
improvement. It seemed to help [my son] knowing
[provider] was checking up daily to see how well he
was doing.”
Areas of improvement almost universally revolved around
caregiver desire to input more information to providers:
“Be able to provide [sic] a few more details.”
“I think a comment space would be nice.”
”Allow for additional comments about behaviors...I
think it would be helpful to include additional
commentary about time of day or specific issues.“
Figure 5. EpxAutism patient overall response rate.
Discussion
Principal Findings
While pharmacology and psychotherapy have made remarkable
progress in addressing patients with adolescent depression and
ASD, there exists a dearth of reliable methods to track symptoms
over time, monitor behavior, and prevent suicidal behaviors.
New ways to leverage mobile technology continue to augment
traditional patient monitoring and treatment options. Electronic
office visits and CBT sessions have robust literature supporting
their efficacy, expanded access to care, time efficiency, and
satisfaction among providers and patients alike [5,32,51].
However, there is a much smaller body of literature describing
the utility and efficacy of mobile apps, phone call platforms,
and text message interventions in adolescent depression and,
especially, ASD. Overall, the literature supports mobile
platforms as promising ways to deliver and improve adherence
to CBT, track symptoms, monitor behavior, and engage patients.
Because landline and texting are ubiquitous forms of
communication, especially in adolescent populations, these
platforms offer a unique angle to improve patient care.
In order to explore text message interventions in adolescent
populations with depression and ASD, we developed 2
automated text message systems called EpxDepression and
EpxAutism. In our initial pilot with EpxDepression, weekly
response rates were very high, whereas overall response rates
on a prompt-by-prompt basis suffered from message fatigue.
Because only the daily mood and sleep prompts showed signal
decay with time, our data suggested that adolescent patients
with depression found daily questions about their mood and
sleep tiresome, unhelpful to their care, or were simply more
engaged with questions asked on the PHQ-9. Patient feedback
indicated that frequency of total prompts was satisfactory with
no complaints about the mood or sleep questions, suggesting a
difference in engagement to these questions attributed to the
lack of perceived usefulness or patient interest. As such, we are
currently modifying the mood and sleep questions within the
EpxDepression algorithm.
Previous studies have shown that subjective mood ratings
submitted over the phone correlate with in-person PHQ-9 scores
[34]. In our small pilot with EpxDepression, we failed to find
a significant correlation between recent mood or sleep scores
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and PHQ-9 scores. However, given our small sample size and
the exploratory nature of this pilot, further investigation will be
necessary to determine whether self-reported subjective mood
and sleep ratings can predict PHQ-9 scores. In addition, due to
the correlation we found between mood and sleep ratings, we
plan on incorporating a split testing method for EpxDepression
and analyzing response rates with or without sleep prompts,
which may help alleviate message fatigue without losing
significant amounts of predictive or clinical information.
Perhaps the most illuminating result from the EpxDepression
pilot was the capability for a text-based PHQ-9 questionnaire
to detect self harm ideation, even before parents and case
managers were made aware. Our data is in line with the
spontaneous success of text-based hotlines, and may reveal the
willingness of adolescents to disclose more personal information
about their mental health to electronic devices, which feel less
judgmental than face-to-face disclosure [37-39,57]. As such,
an inexpensive, proactive, phone-based depression monitoring
platform such as EpxDepression may be a valuable tool not
only to track mood, sleep, and depressive symptoms between
visits, but also to detect suicidal ideation and even prevent
suicidal events. We are currently piloting the second iteration
of EpxDepression in a larger study to confirm our preliminary
findings reported in this pilot.
In our initial pilot with EpxAutism, we found remarkably high
weekly and overall response rates that did not appear to decay
significantly with time. Though larger studies are needed, if this
trend holds true, the difference in overall response rates between
our pilot with EpxAutism and our pilot with EpxDepression
may be attributed to a difference in user motivation,
demographics, or a perceived benefit of each question on the
user’s care. Of note, the patient population was particularly
different between studies, where users enrolled in EpxAutism
were caregivers responsible for their children’s health, whereas
EpxDepression was used by adolescents themselves. Future
interventions for EpxDepression may be able to utilize the
increased caregiver engagement to build complementary
monitoring systems, such as a depression intervention for the
adolescent patient involving the patient’s parents or caregivers.
Consideration for ways to develop EpxAutism in the future to
meet further needs are extensive. Caregiver feedback indicating
desire for more input is being examined. Currently, due to
feedback from psychiatrists involved in the study, patients are
being enrolled who will receive additional daily questions about
quantity of meltdowns including dangerous behaviors
(specifically self-injurious behavior, aggression, and disruption).
Careful consideration will be taken not to drastically increase
the number of daily messages and therefore subject users to
increased message fatigue. Hand-written daily journals and
optional free-text message responses for caregivers are potential
solutions for caregivers who wish to provide more information
while simultaneously avoiding overwhelming those who do not.
A natural extension to monitoring meltdowns in patients with
ASD is empowering families with knowledge and guidance in
order to reduce the quantity and duration of such episodes.
EpxAutism is exploring using the Epharmix text messaging
platform to periodically send caregivers information that teaches
them to provide competent applied behavior analysis (ABA)
techniques aimed at reinforcing appropriate behaviors and
decreasing instances of inappropriate behaviors.
Children with ASD face additional risks that could be addressed
via an automated text messaging platform. These children are
at increased risk for fractures especially during childhood and
adolescent development due to decreased bone density [58]. By
monitoring mealtime behavior, dietary intake, physical activity,
and screen time (time spent using electronic devices), risk for
decreased bone density could be quantitatively measured
remotely. In addition, children with ASD have increased rates
of gastrointestinal symptoms, as well as changes in satiety and
eating habits, compared to children without autism [59]. Thus,
monitoring gastrointestinal symptoms, changes in weight, diet,
and eating patterns could be a promising way to tailor text-based
interventions for children with ASD.
Conclusion
Phone and text message interventions offer a promising,
inexpensive platform to increase access to care for adolescent
patients with depression and ASD and give providers a method
to track symptoms and behaviors with unprecedented temporal
resolution. The unique iteration cycle that we developed with
Epharmix enables rapid conversion of feedback from patients
and providers into optimized platforms for further testing. We
envision EpxDepression and EpxAutism as stepping stones
toward replacing traditional behavioral tracking, which is often
limited by access and is biased by retrospective completion.
While we discussed 2 interventions in this review, we developed
a number of additional interventions within the scope of
behavioral health and are currently running multiple pilot studies
in parallel to confirm their clinical utility. Our goal is to leverage
our rapid iteration cycles to develop a fully optimized mobile
platform that can be tested in a Phase III RCT. While there are
still many hurdles to overcome in adolescent psychiatry, the
future standard of care may only be a text message away.
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